Trial | NCT00329615  Report issue

Title

Insulin Treatment in Cancer Cachexia
Insulin Treatment in Cancer Cachexia: Effects on Survival, Metabolism and Physical Functioning. A Randomized Prospective Study.

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    135
The study is designed to evaluate whether daily insulin treatment to weight losing cancer patients attenuates progression of cancer cachexia and improves metabolism.
Randomized study with long-term follow-up based on survival, health related quality of life, food intake, resting energy expenditure, body composition, exercise capacity and measurement of metabolic efficiency.
Study Started
Jan 31
2000
Study Completion
Sep 30
2005
Last Update
Aug 21
2009
Estimate

Drug Insulatard, flexpen

Criteria 

Inclusion Criteria:

Weight loss
Systemic solid cancer

Exclusion Criteria:

Diabetes
Brain metastases
Expectant survival of less than 6 months
Serum creatinine above 200 umol/l
Persistent of recurrent fever
Cholestasis
No Results Posted